Table I.

Associations between miR-125b expression and the clinical features of patients with melanoma.

Clinical features	Number, n (%)	miR-125b expression (mean ± standard deviation)	P-value
Sex			0.443
Male	13 (44.83)	0.30±0.18
Female	16 (55.17)	0.38±0.32
Age, years			0.874
≥60	15 (51.72)	0.35±0.27
<60	14 (48.28)	0.34±0.27
Tumor diameter, cm			0.425
≥2	11 (37.93)	0.29±0.29
<2	18 (62.07)	0.38±0.26
Lymph node metastasis			0.001a
No	16 (55.17)	0.46±0.31
Yes	13 (44.83)	0.21±0.11
TNM stage			0.004a
I/II	15 (51.72)	0.47±0.31
III/IV	14 (48.28)	0.21±0.09
Lesion location			0.991
Acral	17 (58.62)	0.35±0.25
Non-acral	12 (41.38)	0.35±0.30

A t-test was used to compare the differences among groups.

^aP<0.01. miR-125, microRNA-125b.